# Mondelez International, Inc. (MDLZ)

> Source: Nexqual · https://nexqual.com/MDLZ · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Mondelez International, Inc. (MDLZ), nexqual.com/MDLZ" · informational, not investment advice.

**Price:** USD 65.19 (+3.91% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 62.74 · day 63.31–65.22 · 52w 51.2–66.65 · market cap $83.2B · NMS

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $39.7B, net income $3.52B (8.9% margin), free cash flow $3.08B (SEC filings).
- Valuation: P/E 23.7x (avg 22.0x at the last 3 fiscal year-ends), EV/EBITDA 17.9x, net debt $17.0B.
- 4 of 80 tracked superinvestors hold MDLZ (13F, Q2 2026): 1 new, 0 added, 2 reduced, 1 unchanged.
- Analysts: Buy (mean 2.13 on a 1–5 scale) (23 analysts), mean target USD 69.09 (range 55–77).
- Total return with dividends: 1Y +10.7% vs S&P 500 +14.9%; 5Y +23.3% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 0.71, revenue estimate $9.99B.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $28.7B | $31.5B | $36.0B | $36.4B | $38.5B | $39.7B |
| Gross profit | $11.3B | $11.3B | $13.8B | $14.3B | $10.9B | — |
| Operating income | $4.65B | $3.53B | $5.50B | $6.34B | $3.55B | $4.45B |
| Net income | $4.30B | $2.72B | $4.96B | $4.61B | $2.45B | $3.52B |
| EPS (diluted) | $3.04 | $1.96 | $3.62 | $3.42 | $1.89 | — |
| Free cash flow | $3.18B | $3.00B | $3.60B | $3.52B | $3.23B | $3.08B |
| Gross margin | 39.2% | 35.9% | 38.2% | 39.1% | 28.4% | — |
| Operating margin | 16.2% | 11.2% | 15.3% | 17.4% | 9.2% | 11.2% |
| Net margin | 15.0% | 8.6% | 13.8% | 12.7% | 6.4% | 8.9% |
| Revenue growth | +8.0% | +9.7% | +14.4% | +1.2% | +5.8% | — |
| Cash + short-term investments | $3.55B | $1.95B | $1.88B | $1.40B | $2.19B | — |
| Total debt | $19.3B | $22.6B | $19.0B | $17.7B | $19.9B | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 23.7x · P/S 2.1x · EV/EBITDA 17.9x · EV/Sales 2.5x · P/FCF 27.0x · P/B 3.1x · FCF yield 3.71% · Earnings yield 4.23% · Dividend yield (paid, TTM) 3.05% · Buyback yield (TTM) 1.13% · Net debt $17.0B · EV $100B
P/E at fiscal year-ends: Dec 2025 28.5x, Dec 2024 17.4x, Dec 2023 20.0x.

## Superinvestors (SEC 13F-HR, Q2 2026)
4 of 80 tracked investors hold MDLZ. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Lindsell Train |  | 5.64% | $148M | Reduced -28.0% |
| Bill Nygren | Oakmark Funds | 0.42% | $319M | Reduced -2.0% |
| Lee Ainslie | Maverick Capital | 0.01% | $602K | New position |
| Dodge & Cox Funds | Dodge & Cox | <0.01% | $685K | Unchanged |

## Analysts
Consensus Buy (mean 2.13 on a 1–5 scale), 23 analysts; mean target USD 69.09 (low 55, high 77).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-16 | Barclays | Target raised | Overweight | $70 → $72 |
| 2026-10-16 | JP Morgan | Target lowered | Overweight | $72 → $71 |
| 2026-10-05 | Wells Fargo | Target lowered | Overweight | $70 → $65 |
| 2026-07-30 | Barclays | Target raised | Overweight | $68 → $70 |
| 2026-07-29 | BNP Paribas | Target raised | Outperform | $68 → $70 |
| 2026-07-29 | JP Morgan | Target raised | Overweight | $70 → $72 |
| 2026-07-29 | TD Cowen | Target raised | Buy | $67 → $70 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +10.7% | +23.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +10.7% | +4.3% |
| Volatility (annualized) | 23.6% | 20.2% |
| Max drawdown | -15.7% (Oct 2025→Jan 2026) | -26.2% (Jan 2024→Dec 2025) |

## Peers (Confectioners)
HSY (The Hershey Company) USD 175.64 +4.67% · TR (Tootsie Roll Industries, Inc.) USD 37.19 +2.17% · CL (Colgate-Palmolive Company) USD 97.39 +4.27% · MNST (Monster Beverage Corporation) USD 47.3 +1.44% · TGT (Target Corporation) USD 158.11 +3.76% · MO (Altria Group, Inc.) USD 76.07 +3.03%

## More
Full page: https://nexqual.com/MDLZ · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $0.71 | $0.76 | -6.2% | $9.99B | 17 |
| Next quarter (ends 2026-12-31) | $0.94 | $0.94 | +0.6% | $10.74B | 17 |
| Current fiscal year (ends 2026-12-31) | $3.05 | $3.05 | -0.0% | $40.09B | 23 |
| Next fiscal year (ends 2027-12-31) | $3.36 | $3.37 | -0.4% | $41.20B | 23 |